1Bristol Urological Institute 2Astellas Pharma Europe B.V.

Slides:



Advertisements
Similar presentations
NICE LUTS Clinical Guideline 2010
Advertisements

Urodynamic Findings and Diagnosis in Aging People
Benign Prostatic Hyperplasia Dr.Bandar Al Hubaishy Urology Department KAUH.
EPIDEMIOLOGY AND BIOSTATISTICS DEPT Esimating Population Value with Hypothesis Testing.
Research methods and statistics
Journal Club Alcohol, Other Drugs, and Health: Current Evidence September-October 2007.
Lower urinary tract symptoms (LUTS) in elderly males
What Impact Does a Nurse Training Program Designed to Decrease Urinary Catheter Use Have on Bacteruria Rates in the Community Hospital Setting? Jamie Bartley.
Lower Urinary Tract Symptoms in Men
Nursing approaches for urgency and Urge Incontinence
2008. Causes of symptoms  Hyperplasia of epithelial and stromal components of prostate  Progressive obstruction of urinary outflow  Increased activity.
LUTS Shawket Alkhayal Consultant Urological Surgeon Benenden Hospital Tunbridge Wells Nuffield Hospital.
Study day clinical cases nd Seminar Clinical cases in urodynamics. One morning with Paul Abrams Presented by: Dr. Jose Emilio Batista Centro Médico.
Check your knowledge in… BHP/LUTS. 5-alpha-reductase inhibitors in the treatment of BPH Induce a significant decrease of libido 2 - Increase maximum.
GERIATRICS : UI Dr. Meg-angela Christi Amores. URINARY INCONTINENCE  major problem for older adults, afflicting up to 30% of community-dwelling elders.
Unequal Utilization of New Technologies by Race The Use of New Prostate Surgeries (TUNA and TUMT) among Medicare Elderly Beneficiaries Xinhua Yu, PhD,
Comments for Anatomy, Physiology and Urodynamics Hann-Chorng Kuo Department of Urology Buddhist Tzu Chi General Hospital.
Sacral Neuromodulation in 52 Patients Suffering From Bladder Disorders and/or Pelvic Pain G. Babbolin G. Colini Baldeschi.
Study day clinical cases nd Seminar Clinical cases in urodynamics. One morning with Paul Abrams Presented by: Dr. Jose Emilio Batista Urodynamics.
Paediatric Urodynamics Divyesh Desai Paediatric Urologist Director, Paediatric Urodynamics Unit Great Ormond Street Hospital for Children NHS Trust.
International Neurourology Journal 2015;19: Comparison Between Ambulatory and Conventional Urodynamics of the Modified Orthotopic Hautmann Neobladder.
COMMUNITY CONTINENCE ADVISORY SERVICE SHIRLEY BUDD CONTINENCE CLINICAL LEAD Continence Assessments 1.
Noninvasive Urodynamic Evaluation Carlos Arturo Levi D’Ancona, Jose Bassani, João Carlos Almeida Division of Urology and Bioengineering, University of.
1 GreenLight XPS™ Laser Therapy System The GOLIATH Study.
Interna tional Neurourology Journal 2010;14:26-33 Predictors of Postoperative Voiding Dysfunction following Transobsturator Sling Procedures in Patients.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( org/licenses/by-nc/3.0/)
Volume 50, Issue 3, Pages (September 2006)
Nonparametric Statistics
International Neurourology Journal 2015;19:
Algorithms of Incontinence Management Men
Urology & Nephrology Center, Mansoura, EGYPT
Assessment and management of male lower urinary tract symptoms (LUTS)
International Neurourology Journal 2014;18:
International Neurourology Journal 2015;19:
#96 Roles Of Urodynamics In the Assessment of Post Radical
Dr Kiran Ashok Urogynecologist
Integrated microRNA-mRNA profiling identifies molecular biomarkers in bladder outlet obstruction-induced lower urinary tract dysfunction Fiona C. Burkhard1,
A. Uren1, N. Cotterill1, C. Harding2, C. Hillary3, C. Chapple3, M
Minoru Miyazato, Asuka Ashikari, Takuma Oshiro, and Seiichi Saito
Predictors of Longterm Sacral Nerve Stimulation Failures
Basic Statistics Overview
497 MIRABEGRON IS A SAFE AND EFFECTIVE TREATMENT FOR PARKINSON’S DISEASE PATIENTS WITH STORAGE SYMPTOMS REFRACTORY TO ANTIMUSCARINICS Soto Troya I1 , Park.
PHQ2 Screening Negative PHQ2 Screening Positive
Understanding Standards Event Higher Statistics Award
Incontinence: The Engineering Challenge XI
Management of Male OAB; Current Status in Japan
Jose D Roman M.D. Braemar Hospital, Hamilton, NEW ZEALAND
UKCS 2018 Multivariate analysis of variance for maximising the diagnosing accuracy in differentiating DU from BOO in males Presentation by Rui Li Supervisors:
Assessment and management of male lower urinary tract symptoms (LUTS)
Debra E. Irwin, Ian Milsom, Zoe Kopp, Paul Abrams  European Urology 
Filling Cystometry Carlos D’Ancona, Mario João Gomes, Peter F.W.M. Rosier.
Nonparametric Statistics
ICI-RS Pre-meeting Rui Li
Volume 63, Issue 1, Pages (January 2013)
Evaluation and Medical Management of Benign Prostatic Hyperplasia
Nat. Rev. Urol. doi: /nrurol
Volume 60, Issue 1, Pages (July 2011)
Volume 56, Issue 1, Pages (July 2009)
Volume 69, Issue 2, Pages (February 2016)
Logistic Regression.
P8-2 Rezum water vapour thermal therapy for benign prostatic hyperplasia: early results from the United Kingdom Max Johnston1, Tina Gehring1, James Montgomery1,
International Neurourology Journal 2015;19:
Portable Biofeedback for Bladder Control
Figure 1 Changes in LUT function associated with ageing
Case-control studies: statistics
Primary outcome and patient reported secondary outcomes in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia receiving.
Functional secondary outcome parameters in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia receiving prostatic artery.
ICS TEACHING MODULE Urodynamics in children Part 2
Urinary Retention.
Presentation transcript:

1Bristol Urological Institute 2Astellas Pharma Europe B.V. Symptoms and Signs to distinguish Detrusor Underactivity from Mixed Detrusor Underactivity and Bladder Outlet Obstruction in Male Patients Andrew Gammie1, Satoshi Yoshida2, Achim Steup2, Mathilde Kaper2, Caroline Dorrepaal2, Ton Kos2, Paul Abrams1 1Bristol Urological Institute 2Astellas Pharma Europe B.V. Hypothesis / aims of study  It has been recognised that detrusor underactivity (DU) is one of the preoperative factors that mitigates against a good outcome from prostate surgery in men. Hence, if there were effective non-surgical treatments for DU, and its clinical syndrome underactive bladder (UAB), these would offer men considerable advantages. As both DU and bladder outlet obstruction (BOO) affect voiding function, they can be expected to have many similar features with respect to lower urinary tract symptoms (LUTS), flow rates and post void residual urine. The aim of this study was to see whether there are features that allow DU to be distinguished from DU combined with BOO without the need for catheter urodynamic studies (UDS), as at present. Study design, materials and methods  Symptomatic, urodynamic and other data, from a large computer database, were analysed retrospectively. Differences between DU and BOO patients have been published previously [1]. As a follow-up, in this analysis, symptoms and signs which showed a statistically significant difference between DU and DU+BOO were identified. DU was defined as bladder contractility index (BCI) < 100, bladder voiding efficiency (BVE) < 90%, and bladder outlet obstruction index (BOOI) < 20. DU+BOO was defined as BCI < 100, BVE < 90%, and BOOI >= 40. Logistic regression models including patient group and age as factors were used for each binary variable. Rank ANCOVA models using patient group as factor and age as covariate were used for each numerical variable. Male data were available for 129 DU and 60 DU+BOO patients, none of whom had neurological symptoms nor detrusor overactivity during urodynamics. Interpretation of results  In the DU males, compared to the DU+BOO males, the following statistically significant differences were observed: The number of daytime micturitions were lower, and slow stream was reported less often, whereas a history of transurethral resection surgery and urinary tract infections were reported more often in the DU group. Volume at first desire to void, maximum bladder capacity, voided volume and abdominal pressure at maximum flow were greater in the DU group. Knowledge of these differences can guide the clinician as to the likelihood of a patient fitting the profile of a particular group. Further research could combine these likelihoods to better enable distinguishing between patient groups. The reporting of incontinence in these patients needs further investigation, since the data is from patients without DO in the urodynamic test, and urge incontinence would therefore not be expected to occur. Comparisons with other databases will be necessary to see if this is an artefact of the questionnaire used or whether it is a real phenomenon. Table / Figure 1. Statistically significant continuous variables compared between men with DU and with combined DU and BOO. Table entries are the numbers of patients with non-missing data, above variable median values (1st quartile – 3rd quartile). Table / Figure 2. Statistically significant binary variables compared between men with DU and with combined DU and BOO. Table entries are the number of patients / number of that group with reported variable (with %) and Odds Ratio (95% confidence interval range) of DU versus DU & BOO. NA is stated where odds ratio and p-value are not estimable since n=0. Odds ratio < 1 indicates the variable was reported less for DU patients than for DU & BOO patients Odds ratio > 1 indicates the variable was reported more for DU patients than for DU & BOO patients Concluding message  These preliminary data suggest that by combining symptoms (e.g. straining), with features of the medical history (e.g. prostate surgery), and signs that could be measured without the need for invasive UDS (e.g. bladder capacity), it may be possible to identify men with UAB secondary to DU in a non-invasive way. By doing so, men with DU could be separated from men with both DU and BOO, with sufficient specificity to allow the use of any new treatment modalities. References 1. Gammie A, Kaper M, Dorrepaal C, Kos T, Abrams P. Signs and Symptoms of Detrusor Underactivity: An Analysis of Clinical Presentation and Urodynamic Tests From a Large Group of Patients Undergoing Pressure Flow Studies. Eur Urol. 2016; 69:361-9. This project is supported by a grant from Astellas Pharma Europe BV.